Literature DB >> 31740808

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.

Nora Liebers1,2, Tobias Roider1,3, Jan-Paul Bohn4, Isabella Haberbosch1, Andreas Pircher4, Barbara Ferstl5, Monika Ebnöther6, Clemens-Martin Wendtner7, Claire Dearden8, George A Follows9, Anthony D Ho1, Carsten Müller-Tidow1,2, Peter Dreger1, Xavier Troussard10, Thorsten Zenz11, Sascha Dietrich12,13,14.   

Abstract

Entities:  

Year:  2019        PMID： 31740808     DOI： 10.1038/s41375-019-0646-y

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.

Authors:  Alessandro Broccoli; Carolina Terragna; Laura Nanni; Marina Martello; Silvia Armuzzi; Claudio Agostinelli; Alice Morigi; Beatrice Casadei; Cinzia Pellegrini; Vittorio Stefoni; Elena Sabattini; Lisa Argnani; Pier Luigi Zinzani
Journal:  Hematol Oncol       Date:  2021-10-15       Impact factor: 4.850

Review 2.  Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine.

Authors:  Jan-Paul Bohn; Sascha Dietrich
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.